CKW Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

CKW Financial Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6K	Hold	10	–	–	﹤0.01%	130
2026 Q1	$8K	Hold	10	–	–	﹤0.01%	111
2025 Q4	$8K	Hold	10	–	–	﹤0.01%	127
2025 Q3	$6K	Hold	10	–	–	﹤0.01%	138
2025 Q2	$5K	Hold	10	–	–	﹤0.01%	143
2025 Q1	$6K	Sell	10 -100	-91%	-$68.8K	﹤0.01%	142
2024 Q4	$78K	Hold	110	–	–	0.01%	108
2024 Q3	$115K	Hold	110	–	–	0.01%	83
2024 Q2	$116K	Hold	110	–	–	0.01%	81
2024 Q1	$107K	Hold	110	–	–	0.01%	87
2023 Q4	$97K	Hold	110	–	–	0.01%	90
2023 Q3	$91K	Hold	110	–	–	0.01%	88
2023 Q2	$79K	Hold	110	–	–	0.01%	103
2023 Q1	$90K	Hold	110	–	–	0.01%	72
2022 Q4	$79K	Hold	110	–	–	0.01%	81
2022 Q3	$76K	Hold	110	–	–	0.01%	85
2022 Q2	$65K	Hold	110	–	–	0.01%	99
2022 Q1	$76K	Buy	110 +100	+1,000%	+$63.3K	0.01%	105
2021 Q4	$10K	Hold	10	–	–	﹤0.01%	194
2021 Q3	$6K	Buy	+10	New	+$6.21K	﹤0.01%	199

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

CKW Financial Group's REGN Position: Q2 2026 in Review

CKW Financial Group held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 10 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #130.

CKW Financial Group first reported a position in REGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $116K in Q2 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

CKW Financial Group held 10 shares of Regeneron Pharmaceuticals worth $6K as of Q2 2026.
CKW Financial Group left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of CKW Financial Group's portfolio in Q2 2026, its #130 holding.
CKW Financial Group first reported a position in Regeneron Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
CKW Financial Group's Regeneron Pharmaceuticals position peaked at $116K in Q2 2024.
1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on CKW Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.